Cargando…
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a key enzyme involved in the trimming of antigenic peptides presented by Major Histocompatibility Complex class I. It is a target of growing interest for the treatment of autoimmune diseases and in cancer immunotherapy. However, the discovery of pote...
Autores principales: | Camberlein, Virgyl, Fléau, Charlotte, Sierocki, Pierre, Li, Lenong, Gealageas, Ronan, Bosc, Damien, Guillaume, Valentin, Warenghem, Sandrine, Leroux, Florence, Rosell, Melissa, Cheng, Keguang, Medve, Laura, Prigent, Mathilde, Decanter, Myriam, Piveteau, Catherine, Biela, Alexandre, Eveque, Maxime, Dumont, Julie, Mpakali, Anastasia, Giastas, Petros, Herledan, Adrien, Couturier, Cyril, Haupenthal, Jörg, Lesire, Laetitia, Hirsch, Anna K. H., Deprez, Benoit, Stratikos, Efstratios, Bouvier, Marlene, Deprez‐Poulain, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558494/ https://www.ncbi.nlm.nih.gov/pubmed/35904863 http://dx.doi.org/10.1002/anie.202203560 |
Ejemplares similares
-
Can ERAP1 and ERAP2 Form Functional Heterodimers? A Structural Dynamics Investigation
por: Papakyriakou, Athanasios, et al.
Publicado: (2022) -
The Structures and Binding Modes of Small-Molecule Inhibitors of Pseudomonas aeruginosa Elastase LasB
por: Camberlein, Virgyl, et al.
Publicado: (2022) -
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
por: Lesire, Laetitia, et al.
Publicado: (2022) -
ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing
por: Chen, Hanna, et al.
Publicado: (2016) -
The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I
por: Mavridis, George, et al.
Publicado: (2021)